Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases  

作　　者：Ao Wang Yi Zhang Xinting Lv Guang Liang 

机构地区：[1]Department of Pharmacy and Institute of Inflammation,Zhejiang Provincial Affiliated People’s Hospital,Hangzhou Medical College,Hangzhou 310014,China [2]Key Laboratory of Natural Medicines of the Changbai Mountain,Ministry of Education,Yanbian University,Yanji 133002,China [3]Chemical Biology Research Center,School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China

出　　处：《Acta Pharmaceutica Sinica B》2024年第8期3295-3311,共17页药学学报（英文版）

基　　金：supported by National Natural Science Foundation of China(81930108 to Guang Liang);Zhejiang Provincial Key Scientific Project(2021C03041 to Guang Liang,China).

摘　　要：Protein tyrosine phosphorylation is a post-translational modification that regulates protein structure to modulate demic organisms’homeostasis and function.This physiological process is regulated by two enzyme families,protein tyrosine kinases(PTKs)and protein tyrosine phosphatases(PTPs).As an important regulator of protein function,PTPs are indispensable for maintaining cell intrinsic physiology in different systems,as well as liver physiological and pathological processes.Dysregulation of PTPs has been implicated in multiple liver-related diseases,including chronic liver diseases(CLDs),hepatocellular carcinoma(HCC),and liver injury,and several PTPs are being studied as drug therapeutic targets.Therefore,given the regulatory role of PTPs in diverse liver diseases,a collated review of their function and mechanism is necessary.Moreover,based on the current research status of targeted therapy,we emphasize the inclusion of several PTP members that are clinically significant in the development and progression of liver diseases.As an emerging breakthrough direction in the treatment of liver diseases,this review summarizes the research status of PTP-targeting compounds in liver diseases to illustrate their potential in clinical treatment.Overall,this review aims to support the development of novel PTP-based treatment pathways for liver diseases.

关 键 词：Tyrosine phosphorylation PTPs Signal transduction CLDs HCC Allosteric inhibitor PROTACs Drug development 

分 类 号：R96[医药卫生—药理学]